The future of the recombinant protein market looks promising with opportunities in pharma & biotechnology companies, academic & research institutes, and diagnostic laboratories. The global recombinant protein market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 11.5% from 2023 to 2028. The major drivers for this market are increasing cases of chronic diseases and rise in research and development expenditure on biologics drugs.
Pharma & biotechnology companies are expected to remain the largest end use industry segment due to the increasing the demand for recombinant proteins in drug research for prediction, prognosis, and diagnosis.
North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Answer: The global recombinant protein market is expected to reach an estimated $3.8 billion by 2028.
Q2. What is the growth forecast for recombinant protein market?
Answer: The global recombinant protein market is expected to grow with a CAGR of 11.5% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the recombinant protein market?
Answer: The major drivers for this market are increasing cases of chronic diseases and rise in research and development expenditure on biologics drugs.
Q4. What are the major segments for recombinant protein market?
Answer: The future of the recombinant protein market looks promising with opportunities in pharma & biotechnology companies, academic & research institutes, and diagnostic laboratories.
Q5. Who are the key recombinant protein companies?
Answer: Some of the key recombinant protein companies are as follows:
Answer: The analyst forecasts that antibodies will remain the largest product type segment over the forecast period due to the growing cases of diabetes across the globe.
Q7. In recombinant protein market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Q8. Do we receive customization in this report?
Answer: Yes, the analyst provides 10% Customization Without any Additional Cost.
Q2. Which segments will grow at a faster pace and why?
Q3. Which region will grow at a faster pace and why?
Q4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q5. What are the business risks and competitive threats in this market?
Q6. What are the emerging trends in this market and the reasons behind them?
Q7. What are some of the changing demands of customers in the market?
Q8. What are the new developments in the market? Which companies are leading these developments?
Q9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Recombinant Protein Market by Segment
The study includes trends and forecast for the global recombinant protein market by product type, expression system, application, end use industry, and region, as follows:Recombinant Protein Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Antibodies
- Antigens
- Enzymes
- Hormones
- Others
Recombinant Protein Market by Expression System [Value ($B) Shipment Analysis from 2017 to 2028]:
- Microbes
- Plants
- Animals
Recombinant Protein Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
- Drug Discovery and Development
- Research Application
- Therapeutic Use
- Diagnostics
- Others
Recombinant Protein Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
- Others
Recombinant Protein Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Recombinant Protein Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, recombinant protein companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the recombinant protein companies profiled in this report include-- Abcam
- Sino Biological
- R&D Systems
- GenScript
- Bio-Rad Laboratories
Recombinant Protein Market Insights
The analyst forecasts that antibodies will remain the largest product type segment over the forecast period due to the growing cases of diabetes across the globe.Pharma & biotechnology companies are expected to remain the largest end use industry segment due to the increasing the demand for recombinant proteins in drug research for prediction, prognosis, and diagnosis.
North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Features of the Recombinant Protein Market
- Market Size Estimates: Recombinant protein market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Recombinant protein market size by various segments, such as product type, expression system, application, end use industry, and region
- Regional Analysis: Recombinant protein market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different product types, expression systems, applications, end use industries, and regions for the recombinant protein market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the recombinant protein market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQS
Q1. What is the recombinant protein market size?Answer: The global recombinant protein market is expected to reach an estimated $3.8 billion by 2028.
Q2. What is the growth forecast for recombinant protein market?
Answer: The global recombinant protein market is expected to grow with a CAGR of 11.5% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the recombinant protein market?
Answer: The major drivers for this market are increasing cases of chronic diseases and rise in research and development expenditure on biologics drugs.
Q4. What are the major segments for recombinant protein market?
Answer: The future of the recombinant protein market looks promising with opportunities in pharma & biotechnology companies, academic & research institutes, and diagnostic laboratories.
Q5. Who are the key recombinant protein companies?
Answer: Some of the key recombinant protein companies are as follows:
- Abcam
- Sino Biological
- R&D Systems
- GenScript
- Bio-Rad Laboratories
Answer: The analyst forecasts that antibodies will remain the largest product type segment over the forecast period due to the growing cases of diabetes across the globe.
Q7. In recombinant protein market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to increasing expenditure on research and development and growing number of clinical trials in the region.
Q8. Do we receive customization in this report?
Answer: Yes, the analyst provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q1. What are some of the most promising, high-growth opportunities for the recombinant protein market by product type (hormones, growth factors, enzymes, antibodies, and others), expression system (microbes, plants, and animals), application (research, therapeutics, biotechnology, disease diagnostics, and others), end use industry (pharma & biotechnology companies, academic & research institutes, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q2. Which segments will grow at a faster pace and why?
Q3. Which region will grow at a faster pace and why?
Q4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q5. What are the business risks and competitive threats in this market?
Q6. What are the emerging trends in this market and the reasons behind them?
Q7. What are some of the changing demands of customers in the market?
Q8. What are the new developments in the market? Which companies are leading these developments?
Q9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary2. Global Recombinant Protein Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Recombinant Protein Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Recombinant Protein Market by Product Type
3.3.1: Antibodies
3.3.2: Antigens
3.3.3: Enzymes
3.3.4: Hormones
3.3.5: Others
3.4: Global Recombinant Protein Market by Expression System
3.4.1: Microbes
3.4.2: Plants
3.4.3: Animals
3.5: Global Recombinant Protein Market by Application
3.5.1: Drug Discovery and Development
3.5.2: Research Application
3.5.3: Therapeutic Use
3.5.4: Diagnostics
3.5.5: Others
3.6: Global Recombinant Protein Market by End Use Industry
3.6.1: Biotechnology and Pharmaceutical Companies
3.6.2: Academic and Research Institutes
3.6.3: Contract Research Organizations
3.6.4: Others
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Recombinant Protein Market by Region
4.2: North American Recombinant Protein Market
4.2.1: North American Recombinant Protein Market by Product Type: Antibodies, Antigens, Enzymes, Hormones, and Others
4.2.2: North American Recombinant Protein Market by End Use Industry: Pharma & Biotechnology Companies, Academic & Research Institutes, and Diagnostic Laboratories
4.3: European Recombinant Protein Market
4.3.1: European Recombinant Protein Market by Product Type: Antibodies, Antigens, Enzymes, Hormones, and Others
4.3.2: European Recombinant Protein Market by End Use Industry: Pharma & Biotechnology Companies, Academic & Research Institutes, and Diagnostic Laboratories
4.4: APAC Recombinant Protein Market
4.4.1: APAC Recombinant Protein Market by Product Type: Antibodies, Antigens, Enzymes, Hormones, and Others
4.4.2: APAC Recombinant Protein Market by End Use Industry: Pharma & Biotechnology Companies, Academic & Research Institutes, and Diagnostic Laboratories
4.5: ROW Recombinant Protein Market
4.5.1: ROW Recombinant Protein Market by Product Type: Antibodies, Antigens, Enzymes, Hormones, and Others
4.5.2: ROW Recombinant Protein Market by End Use Industry: Pharma & Biotechnology Companies, Academic & Research Institutes, and Diagnostic Laboratories
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Recombinant Protein Market by Product Type
6.1.2: Growth Opportunities for the Recombinant Protein Market by Expression System
6.1.3: Growth Opportunities for the Recombinant Protein Market by Application
6.1.4: Growth Opportunities for the Recombinant Protein Market by End Use Industry
6.1.5: Growth Opportunities for the Recombinant Protein Market by Region
6.2: Emerging Trends in the Global Recombinant Protein Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Recombinant Protein Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Recombinant Protein Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abcam
7.2: Sino Biological
7.3: R&D Systems
7.4: GenScript
7.5: Bio-Rad Laboratories
Companies Mentioned
- Abcam
- Sino Biological
- R&D Systems
- GenScript
- Bio-Rad Laboratories
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
